Background illustration for clinical trials search

Paid Clinical Trials Newnan

Discover 1,605 paid clinical trials in Newnan, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Thrive With Type 1 Diabetes 2026

for
Type1diabetes
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 31 - 70+

Code: NCT07522866

Recruiting
Active & Responsive

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

for
IgG4 Related Disease
Location: Atlanta GA, Boston MA
Sponsor: Acepodia Biotech, Inc.

Sex: All

Age: 18+

Code: NCT07061938

Phase1, Phase2, Recruiting
Active & Responsive

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for
AML With Gene Mutations
Location: Atlanta GA, Chapel Hill NC, Cincinnati OH, Columbus OH,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06366789

Phase1, Recruiting
Active & Responsive

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

for
Cystic Fibrosis
Location: Atlanta GA, Birmingham AL, Pensacola FL,
Sponsor: Boston Children's Hospital

Sex: All

Age: 6+

Code: NCT06683092

Recruiting
Active & Responsive

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

for
Type 1 Diabetes
Location: Atlanta GA, Chicago IL, Detroit MI, New York NY,
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT07676565

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Location: Atlanta GA, Birmingham AL, St. Petersburg FL,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 6+

Code: NCT05416307

Phase2, Phase3, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Atlanta GA, Birmingham AL, Nashville TN,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

for
Immune Thrombocytopenic Purpura (ITP)
Location: Atlanta GA, Louisville KY, Durham NC, Greenville NC,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06722235

Phase3, Recruiting
Active & Responsive

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

for
Myelodysplastic Syndromes
Location: Atlanta GA, Jacksonville FL, Orlando FL, Tampa FL,
Sponsor: Syntrix Biosystems, Inc.

Sex: All

Age: 18+

Code: NCT04245397

Phase1, Recruiting
Active & Responsive

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

for
Colorectal Cancer
Location: Atlanta GA, Birmingham AL, Nashville TN, Hattiesburg MS,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06562543

Recruiting
Active & Responsive

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP),
Location: Atlanta GA, Jacksonville FL, Tampa FL, St Louis MO,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06798012

Phase2, Recruiting
Active & Responsive

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

for
Small-cell Lung Cancer
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04342429

Recruiting
Active & Responsive

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

for
Ductal Carcinoma in Situ
Location: Atlanta GA, Nashville TN, Winston-Salem NC, Durham NC,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: Female

Age: 18+

Code: NCT06075953

Phase2, Recruiting
Active & Responsive

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

for
Myelofibrosis; Anemia, Anemia, Myelofibrosis,
Location: Atlanta GA, Jacksonville FL, Winston-Salem NC, Tampa FL,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT05320198

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

for
Anemia, Sickle Cell, Healthy Volunteers
Location: Atlanta GA, Birmingham AL, Richmond VA, Fairfax VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06481306

Phase1, Phase2, Recruiting
Active & ResponsiveNew

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

for
Cutaneous Melanoma
Location: Atlanta GA, Birmingham AL, Nashville TN, Corbin KY,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 70+

Code: NCT07068074

Phase3, Recruiting
Active & Responsive

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for
Metastatic Breast Cancer
Location: Atlanta GA, Statesboro GA, Pembroke GA, Forest City NC,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 60+

Code: NCT06377852

Phase3, Recruiting
Active & Responsive

SynKIR-310 for Relapsed/Refractory B-NHL

for
B Cell Lymphoma, NHL, Adult, Mantle Cell Lymphoma,
Location: Atlanta GA, Fairway KS, Philadelphia PA,
Sponsor: Verismo Therapeutics

Sex: All

Age: 18+

Code: NCT06544265

Phase1, Recruiting
Active & Responsive

Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

for
Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04878029

Phase1, Recruiting
Active & Responsive

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

for
Advanced Lung Adenocarcinoma, Refractory Lung Adenocarcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06495125

Phase2, Recruiting